NCT00614705 - PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

December 31, 2008

Conditions

Neuralgia, Postherpetic

Interventions

DRUG

PH-797804

6 mg dose in oral capsule form, once daily for 28 days

DRUG

Placebo

oral capsule form, once daily for 28 days

Trial Locations (25)

11009

Pfizer Investigational Site, Cadiz

28006

Pfizer Investigational Site, Madrid

32005

Pfizer Investigational Site, Ourense

41013

Pfizer Investigational Site, Seville

46014

Pfizer Investigational Site, Valencia

49616

Pfizer Investigational Site, Dnipropetrovsk

61052

Pfizer Investigational Site, Kharkiv

61068

Pfizer Investigational Site, Kharkiv

61178

Pfizer Investigational Site, Kharkiv

65025

Pfizer Investigational Site, Odesa

83045

Pfizer Investigational Site, Donetsk

95006

Pfizer Investigational Site, Simferopol

123098

Pfizer Investigational Site, Moscow

150030

Pfizer Investigational Site, Yaroslavl

194175

Pfizer Investigational Site, Saint Petersburg

194354

Pfizer Investigational Site, Saint Petersburg

2520997

Pfizer Investigational Site, Viña del Mar

581 85

Pfizer Investigational Site, Linköping

114 54

Pfizer Investigational Site, Stockholm

115 22

Pfizer Investigational Site, Stockholm

04050

Pfizer Investigational Site, Kyiv

TN40 1JJ

Pfizer Investigational Site, Bexhill-on-Sea

FY3 7EN

Pfizer Investigational Site, Blackpool

KT15 2BH

Pfizer Investigational Site, Weybridge

B91 2JL

Pfizer Investigational Site, Solihull